Stay updated on JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial

Sign up to get notified when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov site revision identifier changes from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T02:36:34.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The record describes a Phase 1b study of JNJ-67856633 with ibrutinib for B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. It includes the study’s completed status, eligibility criteria, participating locations, treatment plan, and outcome measures.
    Difference
    44%
    Check dated 2026-11-11T01:44:02.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision identifier was updated from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T23:56:40.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology, and the site revision label advances from v3.7.1 to v3.7.2. The study page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-20T23:59:19.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The site's displayed revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:28:58.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating access to the record is blocked. This does not modify the underlying study data but prevents viewing the content.
    Difference
    16%
    Check dated 2026-09-23T00:00:15.000Z thumbnail image

Stay in the know with updates to JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.